| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Awayday secures investment from Warburg Pincus | ||
| Fr | Freedom Broker upgrades Nike stock rating on restructuring plan | ||
| Fr | Jefferies cuts Huntsman stock price target on European challenges | ||
| Fr | Harworth replaces entire board following Peel Group takeover | ||
| Fr | GPI H1 2026 slides: software margins rise as transition year pressures revenue | ||
| Fr | HII promotes Greg Ennis to CFO of Mission Technologies unit | ||
| Fr | Standard Dental Labs acquires Dr. Tooth dental laboratory | ||
| Fr | Tribal Group schedules vote on £231.2m sale to Main Capital | ||
| Fr | Riverstone Energy announces death of non-executive director | ||
| Fr | Capital Metals shareholders approve all AGM resolutions | ||
| Fr | Pfizer reports positive vitiligo trial results for Litfulo | ||
| Fr | Equifax and TransUnion shares fall on mortgage credit report rule change | ||
| Fr | BioMarin presents five-year data on Pompe disease treatment | ||
| Fr | IAG launches final €500m share buyback program | ||
| Fr | Foresight Solar H1 2026 slides: EBITDA on target despite generation miss | ||
| Fr | William Blair reiterates Tesla stock rating after delivery beat | ||
| Fr | BNP Paribas Exane cuts Nike stock price target on weak guidance | ||
| Fr | Cantor Fitzgerald reiterates Rivian stock rating after Q3 beat | ||
| Fr | Travere to present FILSPARI data at ASN Kidney Week 2026 | ||
| Fr | MicroSalt shareholders approve share allotment resolutions | ||
| Fr | Oppenheimer reiterates Perform rating on Tesla stock after deliveries beat | ||
| Fr | EMCOR Group declares $0.40 quarterly dividend | ||
| Fr | Oxford Biomedica grants share options to chief operating officer | ||
| Fr | Climb Bio to present Phase 2 data on kidney disease therapies | ||
| Fr | BMO cuts Constellation Energy stock price target on nuclear deal |